
Innovative and Articulate: Stereotaxis Receives CE Mark, Yet Stock Market Remains Unaware
Stereotaxis’ MAGiC catheter Receives CE Mark Approval in Europe Driving Revenue Growth and Stock Momentum Stereotaxis, a leading provider of robotic technologies for the treatment of cardiac arrhythmias, recently announced that its MAGiC catheter has received CE Mark approval in Europe. This milestone allows the company to earn an additional $3,000 per procedure, with over…